NasdaqGS - Delayed Quote • USD
Alkermes plc (ALKS)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
24.5
47th percentileEnvironmental Risk Score
1.4
Social Risk Score
15.6
Governance Risk Score
7.5
ESG Risk Score for Peers
Name | Total ESG Risk score | E | S | G |
---|---|---|---|---|
KYKOF KYOWA KIRIN CO LTD | 24 | 2 | 14 | 8 |
GNMSF GENMAB AS | 24 | 1 | 16 | 7 |
ALKS Alkermes plc | 24 | 1 | 16 | 7 |
NONOF NOVO NORDISK A/S | 24 | 2 | 13 | 8 |
LLY Eli Lilly and Company | 24 | 3 | 13 | 9 |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 9/2023
ALKS
Category Average
1 Low Controversy Level
None 4 Severe
1.0 ALKS
2.0 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Products and Activities | Significant Involvement |
---|---|
Alcoholic Beverages | No |
Adult Entertainment | No |
Gambling | No |
Tobacco Products | No |
Animal Testing | Yes |
Fur and Specialty Leather | No |
Controversial Weapons | No |
Small Arms | No |
Catholic Values | No |
GMO | No |
Military Contracting | No |
Pesticides | No |
Thermal Coal | No |
Palm Oil | No |
Related Tickers
IRWD Ironwood Pharmaceuticals, Inc.
7.82
-3.22%
DCPH Deciphera Pharmaceuticals, Inc.
14.65
+3.31%
NBIX Neurocrine Biosciences, Inc.
135.99
-1.28%
AMPH Amphastar Pharmaceuticals, Inc.
41.11
+0.69%
SUPN Supernus Pharmaceuticals, Inc.
30.07
+2.59%
INDV Indivior PLC
17.58
+1.91%
PRGO Perrigo Company plc
31.94
+2.14%
COLL Collegium Pharmaceutical, Inc.
36.42
+1.62%
ANIP ANI Pharmaceuticals, Inc.
65.36
+0.63%
ITCI Intra-Cellular Therapies, Inc.
73.26
+1.57%